Market Place
Sourcing Support
Alembic Pharma gets USFDA final approval for Dabigatran Etexilate capsules
19 Jun 2024 //
INDIANPHARMAPOST
Alembic`s Generic Dabigatran Etexilate Mesylate Receives Approval in US
14 Jun 2024 //
FDA
Accord Healthcare`s Dabigatran Etexilate Receives Approval in the Europe
31 May 2023 //
EMA
Enforcement Report - Week of April 5, 2023
05 Apr 2023 //
FDA
Breckenridge Announces Tentative Approval of its ANDA for Dabigatran Etexilate
22 Apr 2022 //
PRNEWSWIRE
Alembic Pharma gets US FDA approval for two of its products
23 Nov 2021 //
PHARMABIZ
Alembic Pharma announces US FDA tentative approval for Dabigatran Etexilate
22 Nov 2021 //
FDA
FDA Approves First Oral Blood Thinning Medication for Children
21 Jun 2021 //
PRNEWSWIRE
Boehringer Ingelheim receives positive CHMP opinion for use of Pradaxa®
16 Nov 2020 //
BUSINESSWIRE
Hetero Lab`s Generic Dabigatran Etexilate Mesylate Receives Approval in US
08 May 2020 //
FDA
Boehringer says Pradaxa found to be safe for recurrent VTE prevention
03 Sep 2019 //
CLINICALTRIALSARENA
New Pfizer, BMS real-world data could boost Eliquis in Europe
03 Sep 2019 //
FIERCE PHARMA
Biohaven, sporting new data, moves closer to CGRP finish line—and maybe M&A
11 Jul 2019 //
FIERCE PHARMA
Safety and efficacy established for Pradaxa in management of VTE in children
09 Jul 2019 //
THE PHARMALETTER
Boehringer Wins Again as California Judge Tosses Pradaxa Lawsuit
04 Feb 2019 //
FDA NEWS
Boehringer Ingelheim presents +ve safety profile of Pradaxa at ESC Congress`18
19 Aug 2018 //
BUSINESSWIRE
FDA Provides Full Approval to Praxbind, Specific Reversal Agent for Pradaxa
17 Apr 2018 //
PR NEWSWIRE
Findings Released from Largest RWD Analysis of Atrial Fibrillation-Direct Oral
12 Mar 2018 //
BUSINESSWIRE
Boehringer Ingelheim to Present New Research on Pradaxa
09 Mar 2018 //
PR NEWSWIRE
FDA Drug Safety Communication: Pradaxa (dabigatran etexilate mesylate)
14 Feb 2018 //
FDA
Oral anticoagulant reversal agent first used in Brazil after regulatory approval
15 Aug 2017 //
PR NEWSWIRE
Final Ph III Study Results Reinforces Safety& Efficacy of Praxbind Agent Pradaxa
11 Jul 2017 //
PR NEWSWIRE
Widower, family face off against J&J & Bayer in next Xarelto bleeding-risk case
02 Jun 2017 //
FIERCE PHARMA
We have a winner: Takeda’s `IBD Superheroes` takes DTC
05 Apr 2017 //
FIERCE PHARMA
Eliquis smashes rivals Xarelto, Pradaxa at cutting bleed-related costs
18 Mar 2017 //
FIERCE PHARMA
Many at risk for stroke don’t get anti-clotting drugs
15 Mar 2017 //
REUTERS
Can Xarelto`s trial win in artery disease help J&J keep rival Eliquis at bay?
09 Feb 2017 //
FIERCE PHARMA
INRatio Blood Monitoring Device Recalled Due to Inaccurate Readings
24 Jan 2017 //
NEWSINFERNO
BMS` Eliquis is `relatively close` to snagging market lead from J&J`s Xarelto
11 Jan 2017 //
FIERCE PHARMA
J&J clot fighter battles Pfizer/Bristol for warfarin
26 Oct 2016 //
FIERCE PHARMA
J&J`s Xarelto may cause more Serious Bleeding than BI`s Pradaxa
08 Oct 2016 //
FIERCE PHARMA
Boehringer`s Pradaxa keeps its antidote edge as FDA swats down Portola contender
22 Aug 2016 //
FIERCE PHARMA
Portola rejection hands advantage to Boehringer`s Pradaxa
20 Aug 2016 //
PMLIVE
Boehringer Ingelheim Launches RE-VECTO Global Program to Capture Data
15 Aug 2016 //
PR NEWSWIRE
Report reveals huge variation in access to anti-stroke drugs
10 May 2016 //
PHARMATIMES
Daiichi caps layoffs drive by melding NJ ops into one smaller HQ
25 Apr 2016 //
FIERCE PHARMA
ACC latest: Lilly, Merck, Pfizer, Novartis and more unveil key data
04 Apr 2016 //
FIERCE PHARMA
Daiichi Sankyo to spend big on M&A, oncology--but more job cuts may be coming
02 Apr 2016 //
FIERCE PHARMA ASIA
Bayer`s Profit Misses Estimates on Decline in Crop Sciences
25 Feb 2016 //
BLOOMBERG
Hoping to jump-start Lixiana, Daiichi Sankyo taps Merck for EU market assault
22 Feb 2016 //
FIERCE PHARMA MARKETING
Praxbind reimbursed in England, Ireland and Wales
17 Feb 2016 //
EUROPEAN PHARMACEUTICLE REVIEW
BMS expects fast-growing Eliquis to take the lead over Xarelto, Pradaxa
03 Feb 2016 //
FIERCE PHARMAMARKETING
Bristol-Myers immunotherapies soar, but Eliquis haul tops the charts
28 Jan 2016 //
FIERCE PHARMA
Fishing for market share, Boehringer Ingelheim casts campaign for Pradaxa
25 Jan 2016 //
FIERCE PHARMA MARKETING
New blood thinner `antidote` to help doctors move past warfarin
23 Dec 2015 //
REUTERS
Beleaguered Daiichi Sankyo shuttering German antibody business
08 Dec 2015 //
FIERCE PHARMA
Boehringer`s Pradaxa antidote gets EU approval
27 Nov 2015 //
PHARMATIMES
FDA Approve Pradaxa for Prophylaxis of Deep Venous Thrombosis
23 Nov 2015 //
PR NEWSWIRE
Portola rolls toward approval for its `breakthrough` anticoagulant antidote
12 Nov 2015 //
FIERCE BIOTECH
BI Present New Praxbind Analyses on Antithrombotic Therapy
09 Nov 2015 //
PR NEWS WIRE
Boehringer Ingelheim picks family member to lead it through tough times
07 Nov 2015 //
FIERCE PHARMA
